CareDx, Inc. is a precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, the Company is focused on improving patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; digital health technologies; and patient solutions that support care before and after transplant. The Company also provides genomic-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.
Back to dashboard
Company Information
About this company
Key people
Michael D. Goldberg
Independent Chairman of the Board
John W. Hanna
President, Chief Executive Officer, Director
Keith Kennedy
Chief Operating Officer, Chief Financial Officer
Jeffrey Adam Novack
General Counsel, Secretary
Jessica Meng
Chief Commercial Officer
Suresh Gunasekaran
Director
George W. Bickerstaff
Independent Director
Frederick E. Cohen
Independent Director
Christine M. Cournoyer
Independent Director
Click to see more
Key facts
- Shares in issue51.73m
- EPICCDNA
- ISINUS14167L1035
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap$2.60bn
- Employees761
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.